Brain-Centered Pharmacology & Pathophysiology
Luca Cucullo, Ph.D., TTUHSC 50th Anniversary Profile School of Pharmacy
There are many reasons why scientists are drawn to their particular fields of research. For some, it may start with a child’s curiosity to learn more about the world in which they live. Others may have been influenced by a family member or friend whose individual circumstances lit a motivational fuse. For Luca Cucullo, Ph.D., it was a series of seeing-is-believing moments that sparked his passion for investigating brain-centered pharmacology/pathophysiology research.
“Probably the strongest input and motivation to pursue my research endeavors as a career path came from my working experience at the Cleveland Clinic’s Department of Neurosurgery because I was directly exposed to the cumbersome challenges patients and care physicians have to deal with,” Cucullo recalls.
As he spent more time at the clinic, Cucullo became acutely aware of the paucity of treatment options available for patients—including children—afflicted with various neurological disorders like drug refractory epilepsy, multiple sclerosis, vascular dementia, stroke and many others. That awareness only added to his desire to help alleviate those health burdens to the best of his ability.
“It is one thing to read from a pathophysiology book about the toll these brain disorders take upon a patient and another to see it happening with your own eyes and realize how bad they can impact someone’s life,” he added.
Cucullo was born and raised in Chieti, a city in southern Italy 124 miles east by northeast of Rome According to mythology, Chieti—Theate or Teate in Latin—was founded in 1181 B.C. by the Homeric Greek hero Achilles and was named in honor of his mother, Thetis.
While preparing his doctoral thesis at the University of Pisa School of Pharmacy, Cucullo was selected from among the school’s best performing graduate students to complete his project at the prestigious Cleveland Clinic.
When his doctoral studies in pharmaceutical technology and biotechnology were completed in 2000, Cucullo was recruited back to the Cleveland Clinic later that same year to conduct research as a post-doctoral research fellow at the hospital’s Cerebrovascular Research Center and began specializing in neuropharmacology and brain vascular modeling.
In 2007, Cucullo accepted a position as a non-tenure track assistant professor at Case Western Reserve University and the Cleveland Clinic Lerner College of Medicine. In 2011, he made his way to the Texas Panhandle by accepting an assistant professor position for the Department of Pharmaceutical Sciences at the TTUHSC School of Pharmacy in Amarillo. In 2018, he was named vice chair of research for the department. He also was granted tenure and promoted to associate professor.
In recent years, Cucullo has started investigating what he describes as an underestimated and often overlooked area relevant to public health: the effect of tobacco smoke exposure on the cerebrovascular system.
“I am focusing primarily on the neurovascular toxicity of various tobacco products and their effects as prodromal agents (early symptoms) to the pathogenesis and progression of major neurological disorders such as stroke, vascular dementia, Alzheimer’s disease and more recently type-2 diabetes.”
Cucullo’s research interest also includes developing models of the microvasculature — the large network of arterioles, capillaries and venules in the body — to enhance scientists’ ability to assess the potential contributions drugs and procedures can make in treating cerebrovascular disease, specific when applied the blood-brain-barrier (BBB).
“Functional and structural impairment of the BBB have been well correlated in recent years as a major prodromal factor for the onset of neurological disorders,” Cucullo explains. “Thus, studies on BBB function are relevant to the pharmacological treatment of central nervous system disorders since the BBB often acts as an impediment to successful drug delivery to neurons. Conversely, it is important to understand BBB function to prevent entry of pathogens or toxins into the brain.”
When he’s not in the classroom or the lab, Cucullo enjoys trail trekking and snorkeling, especially during the summer when he returns to Italy. He also likes to lift weights, tinker with computers and spend time with his family.
“I was blessed to marry a wonderful woman who not only encourages me constantly in my career path, but complements me as a person with her kindness, patience and support,” he says with a smile. “I also have two adorable and talented little mess makers named Luciana and Silvia. They are extremely inquisitive about science—I never thought I would find myself explaining how a black hole is formed to a kindergartener, though it surely did put a big smile on my face. They both make me proud of them every single day.”
The Texas Tech University Health Sciences Center (TTUHSC) Graduate School of Biomedical Sciences hosted its 34th Annual Student Research Week March 8-11.
The National Cancer Institute awarded a five-year, $1.9 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at TTUHSC.
Ericka Hendrix, PhD, MB(ASCP)cm, spoke about the training and education involved for diagnostic molecular scientists and how the pandemic has affected the role.
Celebrating Collaboration — TTUHSC and City of Abilene Unveil New Julia Jones Matthews School of Population and Public Health
TTUHSC and members of the Abilene community today (June 29) celebrated the official unveiling the new Julia Jones Matthews School of Population and Public Health.